Marie Claude Fournié-Zaluski

Aminopeptidase A inhibitors as potential central antihypertensive agents

Annabelle Réaux‐Le Goazigo, Marie Claude Fournié-Zaluski, Christelle David et al. · Proceedings of the National Academy of Sciences · 1999 · 193 citations · Full text

Medicine, Neurobiology, Pharmacology +15

Mixed-inhibitor-prodrug as a new approach toward systemically active inhibitors of enkephalin-degrading enzymes

Marie Claude Fournié-Zaluski, Pascale Coric, Serge Turcaud et al. · Journal of Medicinal Chemistry · 1992 · 141 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

Potent and systemically active aminopeptidase N inhibitors designed from active-site investigation

Marie Claude Fournié-Zaluski, Pascale Coric, Serge Turcaud et al. · Journal of Medicinal Chemistry · 1992 · 88 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

New bidentates as full inhibitors of enkephalin-degrading enzymes: synthesis and analgesic properties

Marie Claude Fournié-Zaluski, Annie Coulaud, Romaine Bouboutou et al. · Journal of Medicinal Chemistry · 1985 · 83 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Evidence of the preferential involvement of .mu.-receptors in analgesia using enkephalins highly selective for peripheral .mu. or .delta. receptors

G. Gacel, Marie Claude Fournié-Zaluski, Etienne Fellion et al. · Journal of Medicinal Chemistry · 1981 · 73 citations · Full text

Medicine, Pharmacology, Physiology +17